Home > Clinical Trials > Methacholine Broncoprovocation Influence of High Potency Corticosteroids in Asthma (MeCIS)

Methacholine Broncoprovocation Influence of High Potency Corticosteroids in Asthma (MeCIS)

Purpose

The American Lung Association and physicians at the Duke Asthma Clinical Research Center are interested in learning more about the influence of high potency corticosteroids on asthma.

Participants with Asthma

The study involves five visits over a three month time period for asthma participants.

Participants with asthma must be diagnosed by a physician and have their asthma under good control, with few or no asthma symptoms during the last four weeks.

Subjects may receive:

  • Allergy skin testing
  • Lung function testing
  • Study medication
  • Compensation for participation

Healthy Participants

The study involves one visit for healthy, or non-asthmatic, participants.

Eligible participants must have no history of asthma or allergies and be a nonsmoker.

Subjects may receive:

  • Allergy skin testing
  • Lung function testing
  • Compensation for participation

Contact Information

If you are interested in participating in this study, e-mail DukeACRC@mc.duke.edu and a coordinator will follow up with you by phone.

For more information, contact Catherine Foss at 919-684-0191.


(REF# 9088)